- Home
- CRIS vs XBP Comparison
CRIS vs XBP Comparison
Compare CRIS & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- XBP
- Stock Information
- Founded
- CRIS 2000
- XBP 2020
- Country
- CRIS United States
- XBP United States
- Employees
- CRIS N/A
- XBP N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- XBP Business Services
- Sector
- CRIS Health Care
- XBP Consumer Discretionary
- Exchange
- CRIS Nasdaq
- XBP Nasdaq
- Market Cap
- CRIS 22.9M
- XBP 71.0M
- IPO Year
- CRIS 2000
- XBP N/A
- Fundamental
- Price
- CRIS $1.67
- XBP $1.00
- Analyst Decision
- CRIS Strong Buy
- XBP
- Analyst Count
- CRIS 2
- XBP 0
- Target Price
- CRIS $16.50
- XBP N/A
- AVG Volume (30 Days)
- CRIS 76.7K
- XBP 392.1K
- Earning Date
- CRIS 11-13-2025
- XBP 11-11-2025
- Dividend Yield
- CRIS N/A
- XBP N/A
- EPS Growth
- CRIS N/A
- XBP N/A
- EPS
- CRIS N/A
- XBP N/A
- Revenue
- CRIS $11,405,000.00
- XBP $148,332,000.00
- Revenue This Year
- CRIS $1.41
- XBP N/A
- Revenue Next Year
- CRIS $7.46
- XBP N/A
- P/E Ratio
- CRIS N/A
- XBP N/A
- Revenue Growth
- CRIS 12.24
- XBP 0.23
- 52 Week Low
- CRIS $1.02
- XBP $0.42
- 52 Week High
- CRIS $6.44
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- CRIS 45.61
- XBP 67.74
- Support Level
- CRIS $1.63
- XBP $0.80
- Resistance Level
- CRIS $1.95
- XBP $1.04
- Average True Range (ATR)
- CRIS 0.15
- XBP 0.10
- MACD
- CRIS 0.00
- XBP 0.05
- Stochastic Oscillator
- CRIS 17.65
- XBP 91.34
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.